{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T12:02:26Z","timestamp":1780142546976,"version":"3.54.0"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017220","name":"Regional Centre for Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017220","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.virusres.2026.199738","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:26:38Z","timestamp":1777494398000},"page":"199738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["HIV envelope pseudotyped virus- an indispensable tool in HIV research"],"prefix":"10.1016","volume":"368","author":[{"given":"Sandhya","family":"Vivekanandan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aanand","family":"Sonawane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7338-1631","authenticated-orcid":false,"given":"Luke Elizabeth","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2026.199738_bib0094","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002634","article-title":"Cell-Cell Transmission Enables HIV-1 to Evade Inhibition by Potent CD4bs Directed Antibodies","author":"Abela","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virusres.2026.199738_bib0039","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00958-20","article-title":"Antigenicity and Immunogenicity of HIV-1 Envelope Trimers Complexed to a Small-Molecule Viral Entry Inhibitor","author":"Alam","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199738_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.mex.2020.101014","article-title":"Modification and optimization of the inhibition of HIV-1 cell-to-cell transmission assay","author":"Alexandre","year":"2020","journal-title":"MethodsX"},{"key":"10.1016\/j.virusres.2026.199738_bib0081","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.10876.1","article-title":"Recent advances in understanding HIV evolution","author":"Andrews","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.virusres.2026.199738_bib0040","doi-asserted-by":"crossref","DOI":"10.1021\/acs.biochem.9b01008","article-title":"Metastable HIV-1 Surface Protein Env Sensitizes Cell Membranes to Transformation and Poration by Dual-Acting Virucidal Entry Inhibitors","author":"Ang","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.virusres.2026.199738_bib0111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251649","article-title":"Identification and evaluation of the inhibitory effect of Prunella vulgaris extract on SARS-coronavirus 2 virus entry","author":"Ao","year":"2021","journal-title":"PLOS ONE."},{"key":"10.1016\/j.virusres.2026.199738_bib0093","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2014.04.004","article-title":"Performance of a clonal-based HIV-1 tropism phenotypic assay","author":"Asin-Milan","year":"2014","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virusres.2026.199738_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048234","article-title":"In Vivo Anti-HIV Activity of the Heparin-Activated Serine Protease Inhibitor Antithrombin III Encapsulated in Lymph-Targeting Immunoliposomes","author":"Asmal","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.virusres.2026.199738_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2007.08.014","article-title":"Production of human immunodeficiency virus type 1 (HIV-1) pseudoviruses using linear HIV-1 envelope expression cassettes","author":"Beels","year":"2008","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virusres.2026.199738_bib0104","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00514-20","article-title":"Differential Pressures of SERINC5 and IFITM3 on HIV-1 Envelope Glycoprotein over the Course of HIV-1 Infection","author":"Beitari","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199738_bib0072","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020617117","article-title":"Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1","author":"Bertagnolli","year":"2020","journal-title":"Proceed. National Acad. Sci."},{"key":"10.1016\/j.virusres.2026.199738_bib0113","doi-asserted-by":"crossref","DOI":"10.1089\/aid.2016.0142","article-title":"Short Communication: potential Risk of Replication-Competent Virus in HIV-1 Env-Pseudotyped Virus Preparations","author":"Bilska","year":"2017","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virusres.2026.199738_bib0116","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00673-09","article-title":"Cross-Subtype Neutralization Sensitivity despite Monoclonal Antibody Resistance among Early Subtype A, C, and D Envelope Variants of Human Immunodeficiency Virus Type 1","author":"Blish","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199738_bib0103","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2018.12.001","article-title":"HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design","author":"Bricault","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virusres.2026.199738_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2008.02.022","article-title":"Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models","author":"Brown","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2026.199738_bib0096","doi-asserted-by":"crossref","DOI":"10.3390\/v12111296","article-title":"Flow Virometry Quantification of Host Proteins on the Surface of HIV-1 Pseudovirus Particles","author":"Burnie","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2026.199738_bib0084","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044163","article-title":"Human Immunodeficiency Virus Type-1 (HIV-1) Continues to Evolve in Presence of Broadly Neutralizing Antibodies More than Ten Years after Infection","author":"Chaillon","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.virusres.2026.199738_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2011.04.042","article-title":"HIV-1 Envelope Glycoprotein Biosynthesis, Trafficking, and Incorporation","author":"Checkley","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virusres.2026.199738_bib0087","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2017.1373922","article-title":"Development and optimization of a sensitive pseudovirus-based assay for HIV-1 neutralizing antibodies detection using A3R5 cells","author":"Chen","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.virusres.2026.199738_bib0053","doi-asserted-by":"crossref","DOI":"10.1097\/QAI.0b013e3181663967","article-title":"Genetic and Neutralization Properties of HIV-1 env Clones From Subtype B\/BC\/AE Infections in China","author":"Chong","year":"2008","journal-title":"JAIDS J. Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.virusres.2026.199738_bib0099","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M112.354126","article-title":"Discovery of Critical Residues for Viral Entry and Inhibition through Structural Insight of HIV-1 Fusion Inhibitor CP621\u2013652","author":"Chong","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virusres.2026.199738_bib0026","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01778-06","article-title":"Broad-Spectrum Anti-Human Immunodeficiency Virus (HIV) Potential of a Peptide HIV Type 1 Entry Inhibitor","author":"Cocklin","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199738_bib0054","article-title":"Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells","author":"Cohen","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199738_bib0041","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00309-13","article-title":"Chimeric Cyanovirin-MPER Recombinantly Engineered Proteins Cause Cell-Free Virolysis of HIV-1","author":"Contarino","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2026.199738_bib0055","doi-asserted-by":"crossref","DOI":"10.3233\/HAB-2005-143-407","article-title":"Characterizing anti-HIV monoclonal antibodies and immune sera by defining the mechanism of neutralization","author":"Crooks","year":"2006","journal-title":"Hum Antibodies"},{"key":"10.1016\/j.virusres.2026.199738_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002251","article-title":"Extremely High Mutation Rate of HIV-1 In Vivo","author":"Cuevas","year":"2015","journal-title":"PLoS Biol."},{"key":"10.1016\/j.virusres.2026.199738_bib0032","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.03339-14","article-title":"Binding Mode Characterization of NBD Series CD4-Mimetic HIV-1 Entry Inhibitors by X-Ray Structure and Resistance Study","author":"Curreli","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2026.199738_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2016.09.057","article-title":"Design, synthesis and evaluation of small molecule CD4-mimics as entry inhibitors possessing broad spectrum anti-HIV-1 activity","author":"Curreli","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.virusres.2026.199738_bib0049","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02853-13","article-title":"Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies","author":"deCamp","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199738_bib0059","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02749-06","article-title":"Dissecting the Neutralizing Antibody Specificities of Broadly Neutralizing Sera from Human Immunodeficiency Virus Type 1-Infected Donors","author":"Dhillon","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199738_bib0034","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00831-17","article-title":"Enfuvirtide (T20)-Based Lipopeptide Is a Potent HIV-1 Cell Fusion Inhibitor: implications for Viral Entry and Inhibition","author":"Ding","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199738_bib0060","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00552-10","article-title":"Variable Loop Glycan Dependency of the Broad and Potent HIV-1-Neutralizing Antibodies PG9 and PG16","author":"Doores","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199738_bib0070","doi-asserted-by":"crossref","DOI":"10.1038\/nature13036","article-title":"Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies","author":"Doria-Rose","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2026.199738_bib0061","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/cix057","article-title":"Virus-driven Inflammation Is Associated With the Development of bNAbs in Spontaneous Controllers of HIV","author":"Dugast","year":"2017","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.virusres.2026.199738_bib0008","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A Third-Generation Lentivirus Vector with a Conditional Packaging System","author":"Dull","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199738_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065965","article-title":"Development of an HIV-1 Microbicide Based on Caulobacter crescentus: blocking Infection by High-Density Display of Virus Entry Inhibitors","author":"Farr","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.virusres.2026.199738_bib0065","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-58371-8","article-title":"Multilayered HIV-1 resistance in HSPCs through CCR5 Knockout and B cell secretion of HIV-inhibiting antibodies","author":"Feist","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.virusres.2026.199738_bib0062","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M111.317776","article-title":"Biochemically Defined HIV-1 Envelope Glycoprotein Variant Immunogens Display Differential Binding and Neutralizing Specificities to the CD4-binding Site","author":"Feng","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virusres.2026.199738_bib0024","doi-asserted-by":"crossref","DOI":"10.1186\/s12977-020-00532-2","article-title":"Longitudinal analysis of subtype C envelope tropism for memory CD4+ T cell subsets over the first 3 years of untreated HIV-1 infection","author":"Gartner","year":"2020","journal-title":"Retrovirology"},{"key":"10.1016\/j.virusres.2026.199738_bib0114","unstructured":"Giorgi, E. Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potential. 2026."},{"key":"10.1016\/j.virusres.2026.199738_bib0110","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27051743","article-title":"Screening of Natural Products Inhibitors of SARS-CoV-2 Entry","author":"Gonz\u00e1lez-Maldonado","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.virusres.2026.199738_bib0066","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20240604","article-title":"Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies","author":"Hahn","year":"2024","journal-title":"J. Experim. Med."},{"key":"10.1016\/j.virusres.2026.199738_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2007.11.009","article-title":"Antiviral compounds show enhanced activity in HIV-1 single cycle pseudovirus assays as compared to classical PBMC assays","author":"Heyndrickx","year":"2008","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virusres.2026.199738_bib0082","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9040311","article-title":"Virus Evolution and Neutralization Sensitivity in an HIV-1 Subtype B\u2032 Infected Plasma Donor with Broadly Neutralizing Activity","author":"Hu","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virusres.2026.199738_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2016.10.027","article-title":"Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth","author":"Huang","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.virusres.2026.199738_bib0090","doi-asserted-by":"crossref","DOI":"10.1007\/BF03256421","article-title":"Phenotypic Analysis of HIV-1 Genotypic Drug-Resistant Isolates from China, Using a Single-Cycle System","author":"Jia","year":"2011","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.virusres.2026.199738_bib0101","doi-asserted-by":"crossref","DOI":"10.1038\/mi.2015.28","article-title":"Identification of preferential CD4+ T-cell targets for HIV infection in the cervix","author":"Joag","year":"2016","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.virusres.2026.199738_bib0063","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003342","article-title":"Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans","author":"Julien","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virusres.2026.199738_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2007.06.044","article-title":"Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody","author":"Klasse","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2026.199738_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.07.015","article-title":"Proteins mimicking epitope of HIV-1 virus neutralizing antibody induce virus-neutralizing sera in mice","author":"Kosztyu","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.virusres.2026.199738_bib0046","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01495-18","article-title":"An HIV-1 Broadly Neutralizing Antibody from a Clade C-Infected Pediatric Elite Neutralizer Potently Neutralizes the Contemporaneous and Autologous Evolving Viruses","author":"Kumar","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199738_bib0105","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58411.sa2","article-title":"Electron tomography visualization of HIV-1 fusion with target cells using fusion inhibitors to trap the pre-hairpin intermediate","author":"Ladinsky","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.virusres.2026.199738_bib0048","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.79.16.10108-10125.2005","article-title":"Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies","author":"Li","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199738_bib0115","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01730-06","article-title":"Genetic and Neutralization Properties of Subtype C Human Immunodeficiency Virus Type 1 Molecular env Clones from Acute and Early Heterosexually Acquired Infections in Southern Africa","author":"Li","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199738_bib0013","doi-asserted-by":"crossref","DOI":"10.2174\/157016212803305989","article-title":"In Vitro Infection of Human Umbilical Cord Blood CD34+ Hematopoietic Progenitor Cells by HIV-1 CRF07_BC Enveloped Pseudovirus","author":"Li","year":"2012","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.virusres.2026.199738_bib0014","article-title":"Critical Amino Acids within the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein V4 N- and C-Terminals Contribute to Virus Entry","author":"Li","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.virusres.2026.199738_bib0001","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.1963","article-title":"Current status on the development of pseudoviruses for enveloped viruses","author":"Li","year":"2018","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.virusres.2026.199738_bib0015","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-019-4375-0","article-title":"HIV-1 subtype C Envelope function becomes less sensitive to N-glycosylation deletion during disease progression","author":"Lumngwena","year":"2019","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.virusres.2026.199738_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227533","article-title":"Selective transmission of some HIV-1 subtype C variants might depend on Envelope stimulating dendritic cells to secrete IL-10","author":"Lumngwena","year":"2020","journal-title":"PLOS ONE"},{"key":"10.1016\/j.virusres.2026.199738_bib0067","doi-asserted-by":"crossref","DOI":"10.2217\/nnm.10.1","article-title":"Emerging Nanotechnology Approaches for HIV\/AIDS Treatment and Prevention","author":"Mamo","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.virusres.2026.199738_bib0097","doi-asserted-by":"crossref","DOI":"10.1016\/j.sjbs.2020.08.034","article-title":"Exploring optical spectroscopic techniques and nanomaterials for virus detection","author":"Manoto","year":"2021","journal-title":"Saudi J Biol Sci"},{"key":"10.1016\/j.virusres.2026.199738_bib0025","doi-asserted-by":"crossref","DOI":"10.2217\/17469600.2.5.479","article-title":"Update on the development of HIV entry inhibitors","author":"Mastrolorenzo","year":"2008","journal-title":"Futur HIV Ther"},{"key":"10.1016\/j.virusres.2026.199738_bib0027","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.C800188200","article-title":"The Antiherpetic Drug Acyclovir Inhibits HIV Replication and Selects the V75I Reverse Transcriptase Multidrug Resistance Mutation","author":"McMahon","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virusres.2026.199738_bib0073","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011469","article-title":"Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials","author":"Mkhize","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virusres.2026.199738_bib0012","doi-asserted-by":"crossref","DOI":"10.1089\/088922200309250","article-title":"Pertussis Toxin Enhances Human Immunodeficiency Virus Type 1 Replication","author":"Momoi","year":"2000","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virusres.2026.199738_bib0058","doi-asserted-by":"crossref","DOI":"10.1097\/COH.0000000000000442","article-title":"Neutralization tiers of HIV-1","author":"Montefiori","year":"2018","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.virusres.2026.199738_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1211s64","article-title":"Evaluating Neutralizing Antibodies Against HIV, SIV, and SHIV in Luciferase Reporter Gene Assays","author":"Montefiori","year":"2004","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.virusres.2026.199738_bib0006","doi-asserted-by":"crossref","DOI":"10.1126\/science.272.5259.263","article-title":"In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector","author":"Naldini","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.virusres.2026.199738_bib0017","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2019.1702479","article-title":"HIV-1 pseudoviruses constructed in China regulatory laboratory","author":"Nie","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.virusres.2026.199738_bib0042","doi-asserted-by":"crossref","DOI":"10.1021\/acs.biochem.6b00570","article-title":"Lytic Inactivation of Human Immunodeficiency Virus by Dual Engagement of gp120 and gp41 Domains in the Virus Env Protein Trimer","author":"Parajuli","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.virusres.2026.199738_bib0043","doi-asserted-by":"crossref","DOI":"10.1042\/BCJ20170662","article-title":"Restricted HIV-1 Env glycan engagement by lectin-reengineered DAVEI protein chimera is sufficient for lytic inactivation of the virus","author":"Parajuli","year":"2018","journal-title":"Biochemical Journal"},{"key":"10.1016\/j.virusres.2026.199738_bib0056","doi-asserted-by":"crossref","DOI":"10.1089\/vim.2010.0061","article-title":"The Importance of Antibody Isotype in HIV-1 Virus Capture Assay and in TZM-bl Neutralization","author":"Peachman","year":"2010","journal-title":"Viral Immunol."},{"key":"10.1016\/j.virusres.2026.199738_bib0023","doi-asserted-by":"crossref","DOI":"10.1186\/s12977-015-0176-2","article-title":"Infection of ectocervical tissue and universal targeting of T-cells mediated by primary non-macrophage-tropic and highly macrophage-tropic HIV-1 R5 envelopes","author":"Peters","year":"2015","journal-title":"Retrovirology"},{"key":"10.1016\/j.virusres.2026.199738_bib0091","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1213409109","article-title":"A mouse model for HIV-1 entry","author":"Pietzsch","year":"2012","journal-title":"Proceed. National Acad. Sci."},{"key":"10.1016\/j.virusres.2026.199738_bib0079","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00423-09","article-title":"The Infectious Molecular Clone and Pseudotyped Virus Models of Human Immunodeficiency Virus Type 1 Exhibit Significant Differences in Virion Composition with Only Moderate Differences in Infectivity and Inhibition Sensitivity","author":"Provine","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199738_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2012.08.005","article-title":"Poly (4-styrenesulfonic acid-co-maleic acid) is an entry inhibitor against both HIV-1 and HSV infections \u2013 Potential as a dual functional microbicide","author":"Qiu","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2026.199738_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00859","article-title":"N-Substituted Pyrrole Derivative 12m Inhibits HIV-1 Entry by Targeting Gp41 of HIV-1 Envelope Glycoprotein","author":"Qiu","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.virusres.2026.199738_bib0019","doi-asserted-by":"crossref","DOI":"10.2174\/157016207780076986","article-title":"Cloning and Characterization of Functional Subtype A HIV-1 Envelope Variants Transmitted Through Breastfeeding","author":"Rainwater","year":"2007","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.virusres.2026.199738_bib0083","doi-asserted-by":"crossref","DOI":"10.1038\/nrg1246","article-title":"The causes and consequences of HIV evolution","author":"Rambaut","year":"2004","journal-title":"Nature Rev. Genetics"},{"key":"10.1016\/j.virusres.2026.199738_bib0022","doi-asserted-by":"crossref","DOI":"10.1089\/aid.2010.0177","article-title":"Construction and Phenotypic Characterization of HIV Type 1 Functional Envelope Clones of Subtypes G and F","author":"Revilla","year":"2011","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virusres.2026.199738_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/biom15010135","article-title":"Pseudotyped Viruses: a Useful Platform for Pre-Clinical Studies Conducted in a BSL-2 Laboratory Setting","author":"Rizatdinova","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.virusres.2026.199738_bib0037","doi-asserted-by":"crossref","DOI":"10.1186\/s13568-019-0915-1","article-title":"Anti-HIV, antitumor and immunomodulatory activities of paclitaxel from fermentation broth using molecular imprinting technique","author":"Ryang","year":"2019","journal-title":"AMB Express"},{"key":"10.1016\/j.virusres.2026.199738_bib0069","article-title":"Correlation Between Circulating HIV-1 RNA and Broad HIV-1 Neutralizing Antibody Activity","author":"Sajadi","year":"2011","journal-title":"JAIDS J. Acquired Immune Defic. Syndr."},{"key":"10.1016\/j.virusres.2026.199738_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.01.010","article-title":"Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody","author":"Schommers","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.virusres.2026.199738_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2019.04.014","article-title":"Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope","author":"Schoofs","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.virusres.2026.199738_bib0092","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051715","article-title":"An Automated HIV-1 Env-Pseudotyped Virus Production for Global HIV Vaccine Trials","author":"Schultz","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.virusres.2026.199738_bib0098","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2024.101702","article-title":"Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines","author":"Schwarzm\u00fcller","year":"2024","journal-title":"Cell Reports Med."},{"key":"10.1016\/j.virusres.2026.199738_bib0057","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02108-09","article-title":"Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies","author":"Seaman","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199738_bib0044","doi-asserted-by":"crossref","DOI":"10.32607\/20758251-2015-7-4-11-21","article-title":"Broadly Neutralizing Antibodies against HIV-1 As a Novel Aspect of the Immune Response","author":"Shcherbakov","year":"2015","journal-title":"Acta Naturae"},{"key":"10.1016\/j.virusres.2026.199738_bib0064","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12121386","article-title":"Induction of Tier 2 HIV-Neutralizing IgA Antibodies in Rhesus Macaques Vaccinated with BG505.664 SOSIP","author":"Smith","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virusres.2026.199738_bib0071","article-title":"Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection","author":"Song","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.virusres.2026.199738_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2012.12.004","article-title":"CD4 detected from Lactobacillus helps understand the interaction between Lactobacillus and HIV","author":"Su","year":"2013","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.virusres.2026.199738_bib0076","series-title":"Progress in Molecular Biology and Translational Science","first-page":"327","year":"2015"},{"key":"10.1016\/j.virusres.2026.199738_bib0112","doi-asserted-by":"crossref","DOI":"10.1080\/14760584.2023.2299380","article-title":"Pseudoviruses, a safer toolbox for vaccine development against enveloped viruses","author":"Thimmiraju","year":"2024","journal-title":"Expert. Rev. Vaccines"},{"key":"10.1016\/j.virusres.2026.199738_bib0088","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2011.09.007","article-title":"Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells","author":"Todd","year":"2012","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.virusres.2026.199738_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25105188","article-title":"Pseudovirus-Based Systems for Screening Natural Antiviral Agents: a Comprehensive Review","author":"Trischitta","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.virusres.2026.199738_bib0028","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkn042","article-title":"CD4 mimetic miniproteins: potent anti-HIV compounds with promising activity as microbicides","author":"Van Herrewege","year":"2008","journal-title":"J. Antimicrobial Chemoth."},{"key":"10.1016\/j.virusres.2026.199738_bib0108","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.11.032","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.virusres.2026.199738_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2017.08.040","article-title":"Synthesis and evaluation of pyridinium polyoxometalates as anti-HIV-1 agents","author":"Wang","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.virusres.2026.199738_bib0106","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.014466","article-title":"HIV-cell membrane fusion intermediates are restricted by Serincs as revealed by cryo-electron and TIRF microscopy","author":"Ward","year":"2020","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.virusres.2026.199738_bib0086","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-020-05288-w","article-title":"Defective HIV-1 envelope gene promotes the evolution of the infectious strain through recombination in vitro","author":"Wei","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.virusres.2026.199738_bib0018","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00853-06","article-title":"Development and Characterization of a Novel Single-Cycle Recombinant-Virus Assay To Determine Human Immunodeficiency Virus Type 1 Coreceptor Tropism","author":"Whitcomb","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2026.199738_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2010.08.006","article-title":"Generation of VSV pseudotypes using recombinant \u0394G-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines","author":"Whitt","year":"2010","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virusres.2026.199738_bib0074","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011780","article-title":"Evolution of HIV-1 envelope towards reduced neutralization sensitivity, as demonstrated by contemporary HIV-1 subtype B from the United States","author":"Wieczorek","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virusres.2026.199738_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2022.126993","article-title":"Application of pseudovirus system in the development of vaccine, antiviral-drugs, and neutralizing antibodies","author":"Xiang","year":"2022","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.virusres.2026.199738_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2016.03.008","article-title":"Comparison of three quantification methods for the TZM-bl pseudovirus assay for screening of anti-HIV-1 agents","author":"Xing","year":"2016","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virusres.2026.199738_bib0020","doi-asserted-by":"crossref","DOI":"10.1086\/524847","article-title":"Blood Monocytes Harbor HIV Type 1 Strains with Diversified Phenotypes Including Macrophage-Specific CCR5 Virus","author":"Xu","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2026.199738_bib0109","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.78.20.11334-11339.2004","article-title":"Small Molecules Blocking the Entry of Severe Acute Respiratory Syndrome Coronavirus into Host Cells","author":"Yi","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199738_bib0075","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv404","article-title":"CATNAP: a tool to compile, analyze and tally neutralizing antibody panels","author":"Yoon","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virusres.2026.199738_bib0038","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2021.1917309","article-title":"Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus","author":"Yu","year":"2021","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.virusres.2026.199738_bib0077","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.79.19.12455-12463.2005","article-title":"Virion Envelope Content, Infectivity, and Neutralization Sensitivity of Simian Immunodeficiency Virus","author":"Yuste","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199738_bib0102","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2017.06.012","article-title":"Fusion Stage of HIV-1 Entry Depends on Virus-Induced Cell Surface Exposure of Phosphatidylserine","author":"Zaitseva","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virusres.2026.199738_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2015.12.012","article-title":"Effect of the maturation of neutralizing antibodies on human immunodeficiency virus (HIV) envelope evolution in HIV-infected subjects","author":"Zhao","year":"2016","journal-title":"Infection, Genetics Evolution"},{"key":"10.1016\/j.virusres.2026.199738_bib0107","doi-asserted-by":"crossref","DOI":"10.1186\/s41256-020-00135-6","article-title":"The novel coronavirus outbreak in Wuhan, China","author":"Zhu","year":"2020","journal-title":"Global Health Res. Policy"},{"key":"10.1016\/j.virusres.2026.199738_bib0068","article-title":"Highly potent and broadly neutralizing anti-CD4 trimeric nanobodies inhibit HIV-1 infection by inducing CD4 conformational alteration","author":"Zhu","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.virusres.2026.199738_bib0021","article-title":"Siglecs Facilitate HIV-1 Infection of Macrophages through Adhesion with Viral Sialic Acids","author":"Zou","year":"2011","journal-title":"PLoS ONE"}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170226000572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170226000572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T11:16:36Z","timestamp":1780139796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170226000572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":116,"alternative-id":["S0168170226000572"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199738","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV envelope pseudotyped virus- an indispensable tool in HIV research","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199738","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"199738"}}